Physician profile
Daniel J Hall
NPI 1891714572
$1,719.77
in general payments reported to CMS, 2019-2025
35 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.58 · 2020: $184 · 2021: $312 · 2022: $191 · 2023: $414 · 2024: $244 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $164.39 | 2019-2025 | |
| Abbott Laboratories | $164.15 | 2019-2025 | Freestyle Libre 3 |
| Medtronic, INC. | $136.12 | 2021 | |
| Access Pro Medical, LLC | $133.28 | 2023 | Matriderm |
| Genzyme Corporation | $109.00 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $96.99 | 2020-2025 | Dupixent, Libtayo |
| Inspire Medical Systems, INC. | $83.99 | 2023-2024 | Inspire |
| Xeris Pharmaceuticals, INC. | $64.68 | 2021-2022 | |
| Lilly USA, LLC | $61.09 | 2023-2025 | Zepbound, Mounjaro, Jardiance |
| Insulet Corporation | $54.59 | 2021-2024 | Omnipod |
| Tandem Diabetes Care, INC. | $49.80 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Stryker Corporation | $46.56 | 2019-2025 | Audion Et Dilation System |
| Novo Nordisk INC | $45.47 | 2023 | Rybelsus |
| Radius Health, INC. | $45.20 | 2024-2025 | |
| Dexcom, INC. | $44.52 | 2025 | Dexcom G6 Transmitter |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $41.51 | 2022-2024 | Evenity, Prolia |
| Intersect Ent, INC. | $38.56 | 2019-2021 | |
| C2dx, INC | $32.94 | 2023 | |
| Merck Sharp & Dohme LLC | $28.12 | 2022-2023 | |
| Zealand Pharma US, INC. | $23.52 | 2021 | |
| Beta Bionics, INC. | $22.43 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Kci USA, INC. | $22.00 | 2020 | |
| Sanofi-Aventis U.S. LLC | $21.58 | 2019 | |
| Halozyme INC | $18.40 | 2023 | |
| Corcept Therapeutics | $17.66 | 2023 | Korlym |
| Recordati_rare_diseases_inc. | $17.37 | 2022 | |
| Eusa Pharma (US) LLC | $17.37 | 2022 | |
| Amryt Pharma Holdings Ltd | $17.25 | 2023 | Mycapssa |
| Alk-Abello, INC | $16.93 | 2020 | |
| Glaxosmithkline, LLC. | $16.92 | 2025 | Nucala |
| Pharming Healthcare, INC. | $15.49 | 2024 | Ruconest |
| Novartis Pharmaceuticals Corporation | $13.83 | 2022 | |
| Olympus America INC. | $13.15 | 2024 | Rhino-Laryngo Videoscope, Gyrus Acmi, INC |
| Organogenesis INC. | $12.65 | 2021 | |
| Shire North American Group INC | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.